Principal investigators and laboratory managers seeking to order GHRP-2 for targeted pituitary and ghrelin-receptor research require strict purity standards and verified lot consistency. PX1 Research provides USA-manufactured GHRP-2 with third-party analytical validation, ensuring high-fidelity results across preclinical assay models.
Principal investigators and laboratory managers seeking to order GHRP-2 for targeted pituitary and ghrelin-receptor research require strict purity standards and verified lot consistency. PX1 Research provides USA-manufactured GHRP-2 with third-party analytical validation, ensuring high-fidelity results across preclinical assay models.
To order GHRP-2 for specialized research applications, procurement departments should source directly through verified chemical synthesis partners that provide full lot traceability. PX1 Research offers laboratory-grade GHRP-2 manufactured in GMP-compliant, USA-based facilities, accompanied by comprehensive third-party batch documentation.
Every batch of GHRP-2 undergoes analytical testing, including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), to confirm chemical identity and guarantee a minimum purity threshold. Orders placed prior to daily cutoff times ship same-day from distribution centers in California and Arizona, providing research teams with reliable cold-chain delivery.
GHRP-2 (Growth Hormone Releasing Peptide-2), chemically known as D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2, is a synthetic hexapeptide classified as a growth-hormone secretagogue (GHS). It functions primarily as an agonist at the growth hormone secretagogue receptor 1a (GHS-R1a), commonly recognized as the ghrelin receptor.
In vitro signaling models demonstrate that GHRP-2 binding to GHS-R1a initiates a G-protein-coupled signaling cascade, activating phospholipase C (PLC) and producing inositol triphosphate (IP3) and diacylglycerol (DAG). This intracellular pathway triggers intracellular calcium ion mobilization within pituitary somatotrophs, prompting the pulsatile release of endogenous growth hormone (GH). Research teams studying growth hormone secretagogues frequently utilize GHRP-2 to evaluate signal transduction pathways and receptor binding affinity.
In preclinical rodent models, GHRP-2 has been extensively evaluated for its potent secretagogue profile. Research indicates that GHRP-2 exhibits a high receptor affinity for GHS-R1a, demonstrating a robust somatotroph response in baseline dynamic monitoring assays.
Preclinical studies suggest that GHRP-2 acts synergistically when co-administered in vitro with endogenous Growth Hormone-Releasing Hormone (GHRH). Unlike direct GHRH receptor stimulation, GHRP-2 operates via distinct intracellular pathways, preventing immediate receptor cross-desensitization. Additionally, animal studies assessing ghrelin axis dynamics highlight GHRP-2 as a stable probe for investigating central appetite signaling and pituitary-adrenal feedback mechanisms.
When designing comparative research protocols, evaluating the potency, receptor selectivity, and signaling profiles of various secretagogues is essential. GHRP-2 is frequently evaluated alongside second- and third-generation secretagogues to observe variance in pituitary hormone release amplitude and secondary axis activation.
In comparative assays, GHRP-6 exhibits higher non-selective ghrelin-receptor-mediated appetite induction pathways in preclinical rodent models, whereas GHRP-2 displays greater binding potency for somatotroph stimulation. Conversely, selective compounds such as Ipamorelin demonstrate minimal activation of secondary hormones (such as cortisol and prolactin) compared to first-generation hexapeptides. Researchers exploring dual-pathway protocols also frequently contrast GHRP-2 mechanisms with GHRH analogs like CJC-1295 No DAC to analyze total pulsatile amplification.
Ensuring experimental reproducibility requires rigorous analytical verification of every research peptide. PX1 Research subjects every lot of GHRP-2 to independent testing at an ISO 17025-accredited laboratory prior to release.
Purity is quantified via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring that target peptide concentration meets or exceeds 99%. Concurrently, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular weight and verifies the absence of truncated peptide fragments or chemical impurities. A batch-specific Certificate of Analysis (COA) detailing these findings is available directly through our research repository.
For cell culture studies and biological assays, bacterial endotoxins introduce significant confounding variables by altering cellular responses and inducing non-specific inflammatory cytokines. PX1 Research enforces stringent endotoxin limits across all synthesized compounds.
Every batch of GHRP-2 undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to verify that endotoxin levels remain below standard research thresholds (<0.5 EU/mg). This quality control standard guarantees that in vitro cell cultures remain uncontaminated by pyrogenic elements, protecting research integrity.
Lyophilized GHRP-2 requires precise reconstitution procedures prior to use in laboratory assays. Research personnel should handle vials under a laminar flow hood using sterile laboratory technique to prevent microbial introduction.
Standard laboratory protocol involves reconstituting the lyophilized cake with sterile target solvents, such as bacteriostatic water (0.9% benzyl alcohol) or sterile laboratory saline, depending on the specific requirements of the downstream assay. Solvent should be introduced slowly down the interior glass wall of the vial, followed by gentle swirling. Mechanical agitation or vigorous shaking must be avoided to prevent shear stress and peptide denaturation.
Lyophilized GHRP-2 exhibits optimal long-term stability when stored at micro-temperatures. Unreconstituted vials should be preserved at -20°C for up to 24 months, isolated from light exposure and humidity fluctuations.
Once reconstituted into solution, GHRP-2 should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade peptide bonds over time. Reconstituted aqueous solutions remain stable at 2°C to 8°C for short-term experimental windows (up to 30 days). For extended analytical series, solutions must be stored at -80°C.
PX1 Research streamlines procurement for university research groups, contract research organizations (CROs), and private biotechnology institutions. Organizations seeking volume supply for ongoing trial series can establish wholesale lab accounts for specialized order processing.
All orders ship directly from centralized fulfillment hubs located in California and Arizona. Utilizing optimized cold-chain packaging practices, PX1 Research ensures rapid domestic dispatch with standard same-day processing for orders submitted Monday through Friday.
What purity level is guaranteed when ordering GHRP-2 from PX1 Research?
PX1 Research guarantees that all GHRP-2 lots meet or exceed a 99% purity threshold, as confirmed by third-party RP-HPLC testing.
How can researchers access the Certificate of Analysis (COA) for a specific GHRP-2 lot?
Certificates of Analysis featuring RP-HPLC chromatograms and mass spectrometry data are accessible directly on our website or by contacting our analytical support team with your lot number.
Is GHRP-2 supplied by PX1 Research tested for endotoxins?
Yes. Every batch undergoes chromogenic LAL endotoxin testing to ensure endotoxin levels are verified below standard laboratory thresholds (<0.5 EU/mg).
Where are PX1 Research peptides synthesized and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona.
What is the recommended storage temp for lyophilized GHRP-2?
Lyophilized GHRP-2 should be stored at -20°C in a dry, dark environment for long-term stability. Upon reconstitution, liquid solutions should be kept at 2°C to 8°C.
What solvents are suitable for reconstituting GHRP-2 in a research setting?
Depending on assay requirements, GHRP-2 is typically reconstituted using sterile bacteriostatic water or sterile 0.9% sodium chloride solution under aseptic laboratory conditions.
How does GHRP-2 differ from GHRP-6 in preclinical research?
In preclinical studies, GHRP-2 demonstrates higher somatotroph secretagogue potency and lower ghrelin-mediated appetite induction compared to GHRP-6.
Can academic institutions establish institutional billing or bulk pricing for GHRP-2?
Yes, academic and commercial research entities can set up verified institutional accounts through our wholesale portal for bulk orders and specialized billing.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.